Vanessa Carle - 26 Oct 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Secretary
Signature
/Vanessa Carle/
Issuer symbol
LEXX
Transactions as of
26 Oct 2023
Net transactions value
$0
Form type
4
Filing time
01 Nov 2023, 13:45:34 UTC
Previous filing
29 Aug 2022
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 67 26 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +12,500 +31% $0.000000 52,567 26 Oct 2023 Common Shares 12,500 $1.15 Direct
holding LEXX Warrants 67 26 Oct 2023 Common Shares 67 $36.00 Direct
holding LEXX Stock Options 12,567 26 Oct 2023 Common Shares 12,500 $3.00 Direct F1
holding LEXX Stock Options 17,567 26 Oct 2023 Common Shares 5,000 $3.00 Direct F2
holding LEXX Stock Options 27,567 26 Oct 2023 Common Shares 10,000 $3.00 Direct F3
holding LEXX Stock Options 40,067 26 Oct 2023 Common Shares 12,500 $2.91 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $5.31 pursuant to shareholder approval received on May 9, 2023
F2 Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
F3 Repriced from $6.23 pursuant to shareholder approval received on May 9, 2023